Status:
WITHDRAWN
Comparison of Priming Constituents in Patients Undergoing CPB Assisted Cardiac Surgery: HES 130/0.4 or Albumin 5%
Lead Sponsor:
University of Saskatchewan
Conditions:
Coronary Artery Disease
Aortic Valve Disease
Eligibility:
All Genders
50-90 years
Phase:
NA
Brief Summary
The purpose of the study is to determine which priming fluid is the safest for use for priming the heart-lung machine used during cardiopulmonary bypass for patients undergoing cardiac surgery. The fl...
Detailed Description
Project title: Comparison of priming constituents in patients undergoing CPB assisted cardiac surgery: 6% HES 130/0.4 or Albumen 5% Principal investigator: Jo-Anne Marcoux M. Sc., CPC, CCP Departm...
Eligibility Criteria
Inclusion
- patients undergoing cardiopulmonary bypass assisted cardiac surgery
- \-
Exclusion
- emergencies and patients in renal failure or dialysis -
Key Trial Info
Start Date :
November 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01849757
Start Date
November 1 2013
End Date
November 1 2017
Last Update
May 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal University Hospital
Saskatoon, Saskatchewan, Canada, S7N 0W8